Currently
Enrolling Studies

check your eligibility

By clicking “Submit,” I consent to Segal Trials using my information for the purpose of evaluating and reporting on my eligibility for this clinical trial. My personal information will only be used for recruitment purposes. For more details, please review our Privacy Policy.

Research Studies »

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275

Segal Trials is currently conducting an outpatient Psychedelic clinical research study evaluating the safety and efficacy of an investigational medication based on psilocybin for patients with Depression.

Participants may qualify if they are:

  • Adults between 21 and 65 years old
  • Diagnosed or experience symptoms of Depression
  • Must be on a stable dose of antidepressant medication
  • Cannot have had exposure to psilocybin, or any other psychedelics such as ayahuasca, mescaline, LSD, peyote, MDMA, ketamine, or esketamine more than 10 times in the last 10 years or any psychedelic use within 6 months before screening
  • Additional Criteria may apply
  • Study length: Up to 84 days

Participants who qualify may receive:

  • Study-related exams & lab work – at no cost
  • Available transportation
  • No insurance is necessary
  • Compensation up to $2,275 for time and travel if qualified

Application for Current
Clinical Research Study

Research Study

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275

Please enter your Full Legal Name
All information provided is confidential and will not be given or sold to any other agency without prior consent.

Join our Waitlist for Upcoming Studies

Sign up below to be notified when we begin the next round of intake.
This is a rich text area, you can add whatever copy you like
Do you live in Miami-Dade, Broward, or West Palm Beach?*
This is a rich text area, you can add whatever copy you like

By clicking “Submit,” I consent to Segal Trials using my information for the purpose of evaluating and reporting on my eligibility for this clinical trial. My personal information will only be used for recruitment purposes. For more details, please review our Privacy Policy.
You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy. By clicking submit below, you consent to allow Segal Trials to store and process the personal information submitted above to provide you the content requested.